Ledger.Open graph →

SEC Form D · filed September 29, 2021

Cerecin Inc

Offering

$30.0M

Sold

$10.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DENVER, CO

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Kikab T. Kim · Denver, CODirector Claude T. Nash · Denver, CODirector Samuel T. Henderson · Denver, COExec Hans-Jurgen S. Woerle · Denver, CODirector Joseph S. Zakrzewski · Denver, CODirector Gurpreet S. Vohra · Denver, CODirector Jerris T. Knaisch · Denver, COExec Charles Stacey · Denver, COExec · Director Wolfgang T. Reichenberger · Denver, CODirector Noah Hershcoviz · Kadima, L3Director Doron Cohen · Kadima, L3Director Yossi Shemesh · Kadima, L3Director Oluwaseun Oyinsan · Millbury, MAExec Walker Moody · Houston, TXDirector Daniel Pickering · Houston, TXDirector Boaz Gorfung · Kadima, L3Exec Robert Ferriol · Portland, ORExec · Director Adam Guggenheim · Palos Verdes Estates, CADirector Nayel M. Nassar · Denver, CODirector Aurora R. Cassirer · Elmsford, NYDirector Maria R. Schroeder · Elmsford, NYExec Peter Kim · Irvine, CAExec Pranay Parikh · Irvine, CADirector Mithulan Jegapragasan · Irvine, CADirector Jeffrey Harris · Boca Raton, FLDirector Sergey Sherman · Boca Raton, FLExec · Director Rishabh Agarwal · New Haven, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗